EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury‐Induced Secondary Damage by Activating PINK1/Parkin‐Mediated Mitophagy and Suppressing ASS1/CPS1‐Driven Arginine Biosynthesis

Yanan He iD, Lu Yu, Yixun Lu iD, Zhikang Zhou, Ao Li, Lu Wang iD, Zhili Huang iD, Yanhong Liu iD, Yulong Ma iD, Weidong Mi iD

CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)

DOI: 10.1002/cns.71146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 09.09.2026. Verfasst von Yanan He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, PQQ Cofactor, Ubiquitin-Protein Ligases, Arginine. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Pyrroloquinoline quinone (PQQ) was reported to be neuroprotective after experimental traumatic brain injury (TBI), but its mechanisms remain undefined. We tested whether PQQ protects against TBI in mice and identified the associated pathways.

Methods

Male C57BL/6 mice received intraperitoneal PQQ (6.25, 12.5 or 25 mg/kg) immediately after controlled cortical impact. Mortality, modified neurological severity score (mNSS) and beam balance were followed to day 14; histopathology, immunofluorescence, western blot, ELISA and ATP assays were performed on day 3. Transcriptomics, metabolomics, network pharmacology and docking were integrated to identify candidate mechanisms.

Results

PQQ reduced mortality (lowest at 12.5 mg/kg) and dose‐dependently improved neurological deficits, neuronal apoptosis, brain edema, pro‐inflammatory cytokines, and oxidative stress; the mNSS and beam balance benefits persisted to day 14. At 12.5 mg/kg, multi‐omics and network pharmacology identified arginine biosynthesis, mediated by argininosuccinate synthetase 1 (ASS1) and carbamoyl phosphate synthetase 1 (CPS1), as the top‐ranked pathway suppressed by PQQ; docking predicted binding of PQQ to both enzymes, suggesting putative targets pending validation. PQQ concurrently restored PTEN‐induced kinase 1 (PINK1)/Parkin‐mediated mitophagy and ATP production.

Conclusion

PQQ attenuates secondary injury after TBI in male mice, in association with increased markers of PINK1/Parkin‐mediated mitophagy initiation and suppressed ASS1/CPS1‐driven arginine biosynthesis, identifying a candidate dual‐axis mechanism and nominating the mitophagy‐arginine axis as a target for neuroprotection in TBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Injuries, TraumaticPQQ CofactorUbiquitin-Protein LigasesArginineMitophagyProtein KinasesNeuroprotective AgentsAnimalsMaleMice, Inbred C57BLMicePTEN-Induced Putative KinaseDose-Response Relationship, Drug

Stichwörter der Autor:innen

ASS1CPS1PINK1/parkinarginine biosynthesismitophagypyrroloquinoline quinonetraumatic brain injury

Substanzen

PQQ CofactorUbiquitin-Protein LigasesArgininePTEN-Induced Putative KinaseProtein Kinasesparkin proteinNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Beijing Key Laboratory of Perioperative Multimodal Digital Intelligence-Integrated Diagnosis and Treatment, Beijing, China.
  • Department of Pharmacology, School of Basic Medical Sciences, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.

ORCID-Profile: Yanan He, Yixun Lu, Lu Wang, Zhili Huang, Yanhong Liu, Yulong Ma, Weidong Mi

Zitieren

APA

He, Y., Yu, L., Lu, Y., Zhou, Z., Li, A., Wang, L., Huang, Z., Liu, Y., Ma, Y., & Mi, W. (2026). Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury‐Induced Secondary Damage by Activating PINK1/Parkin‐Mediated Mitophagy and Suppressing ASS1/CPS1‐Driven Arginine Biosynthesis. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71146

Vancouver

He Y, Yu L, Lu Y, Zhou Z, Li A, Wang L, et al. Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury‐Induced Secondary Damage by Activating PINK1/Parkin‐Mediated Mitophagy and Suppressing ASS1/CPS1‐Driven Arginine Biosynthesis. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71146

BibTeX
@article{He2026,
  author = {He, Yanan and Yu, Lu and Lu, Yixun and Zhou, Zhikang and Li, Ao and Wang, Lu and Huang, Zhili and Liu, Yanhong and Ma, Yulong and Mi, Weidong},
  title = {Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury‐Induced Secondary Damage by Activating PINK1/Parkin‐Mediated Mitophagy and Suppressing ASS1/CPS1‐Driven Arginine Biosynthesis},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {9},
  doi = {10.1002/cns.71146}
}
Kostenlos starten →